[1]
Łukasz Karaban, “GLP-1 Receptor Agonists: Therapeutic Benefits in Renal Function, Cardiovascular Risk, and Physical Activity - A Systematic Review”, Qual Sport, vol. 41, p. 60343, May 2025.